

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleobase biosynthetic process (GO:0046112) | 5.65573844 |
| 2 | purine nucleobase biosynthetic process (GO:0009113) | 5.55354815 |
| 3 | chromatin remodeling at centromere (GO:0031055) | 4.99308708 |
| 4 | CENP-A containing nucleosome assembly (GO:0034080) | 4.85389789 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 4.78108343 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 4.71632827 |
| 7 | folic acid metabolic process (GO:0046655) | 4.66771303 |
| 8 | ribosome assembly (GO:0042255) | 4.15036167 |
| 9 | histone exchange (GO:0043486) | 4.14081593 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.08891129 |
| 11 | mitotic metaphase plate congression (GO:0007080) | 4.07651581 |
| 12 | mitotic nuclear envelope disassembly (GO:0007077) | 4.02588581 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 3.97161996 |
| 14 | DNA replication checkpoint (GO:0000076) | 3.93358900 |
| 15 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.90276186 |
| 16 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.90276186 |
| 17 | DNA replication-independent nucleosome organization (GO:0034724) | 3.87128576 |
| 18 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.87128576 |
| 19 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.86924747 |
| 20 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.86924747 |
| 21 | DNA strand elongation (GO:0022616) | 3.81556209 |
| 22 | regulation of translational termination (GO:0006449) | 3.78064126 |
| 23 | membrane disassembly (GO:0030397) | 3.77601109 |
| 24 | nuclear envelope disassembly (GO:0051081) | 3.77601109 |
| 25 | establishment of viral latency (GO:0019043) | 3.70290738 |
| 26 | DNA double-strand break processing (GO:0000729) | 3.66213143 |
| 27 | DNA damage response, detection of DNA damage (GO:0042769) | 3.62349823 |
| 28 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.60569871 |
| 29 | DNA ligation (GO:0006266) | 3.56408865 |
| 30 | ribosome biogenesis (GO:0042254) | 3.55624306 |
| 31 | DNA replication initiation (GO:0006270) | 3.54925189 |
| 32 | metaphase plate congression (GO:0051310) | 3.54039400 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.51794898 |
| 34 | nuclear pore organization (GO:0006999) | 3.50960562 |
| 35 | protein localization to chromosome, centromeric region (GO:0071459) | 3.49515374 |
| 36 | cullin deneddylation (GO:0010388) | 3.45302865 |
| 37 | mitotic sister chromatid segregation (GO:0000070) | 3.44357010 |
| 38 | formation of translation preinitiation complex (GO:0001731) | 3.44233582 |
| 39 | protein localization to kinetochore (GO:0034501) | 3.40891879 |
| 40 | pre-miRNA processing (GO:0031054) | 3.40572364 |
| 41 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.38816544 |
| 42 | proteasome assembly (GO:0043248) | 3.37173268 |
| 43 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.36486167 |
| 44 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.34382698 |
| 45 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.34382698 |
| 46 | IMP biosynthetic process (GO:0006188) | 3.34131397 |
| 47 | kinetochore organization (GO:0051383) | 3.33637295 |
| 48 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.31494601 |
| 49 | chaperone-mediated protein transport (GO:0072321) | 3.30278259 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.29013152 |
| 51 | protein deneddylation (GO:0000338) | 3.28224537 |
| 52 | sister chromatid segregation (GO:0000819) | 3.28065763 |
| 53 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.25823150 |
| 54 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.25763314 |
| 55 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.24704669 |
| 56 | mRNA cleavage (GO:0006379) | 3.24041395 |
| 57 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.23490209 |
| 58 | regulation of helicase activity (GO:0051095) | 3.22378801 |
| 59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.22269009 |
| 60 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.18904212 |
| 61 | L-serine metabolic process (GO:0006563) | 3.18806319 |
| 62 | regulation of mitochondrial translation (GO:0070129) | 3.17107662 |
| 63 | nuclear envelope organization (GO:0006998) | 3.16624793 |
| 64 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.14615498 |
| 65 | postreplication repair (GO:0006301) | 3.11572057 |
| 66 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.11376219 |
| 67 | IMP metabolic process (GO:0046040) | 3.11295087 |
| 68 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.11184183 |
| 69 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.10137481 |
| 70 | regulation of centriole replication (GO:0046599) | 3.09227474 |
| 71 | kinetochore assembly (GO:0051382) | 3.08499700 |
| 72 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.07139050 |
| 73 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.07139050 |
| 74 | non-recombinational repair (GO:0000726) | 3.06511213 |
| 75 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.06511213 |
| 76 | rRNA modification (GO:0000154) | 3.04724280 |
| 77 | replication fork processing (GO:0031297) | 3.02631107 |
| 78 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.02625382 |
| 79 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.02625382 |
| 80 | rRNA processing (GO:0006364) | 3.01550521 |
| 81 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.99903736 |
| 82 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.99108887 |
| 83 | telomere maintenance via telomere lengthening (GO:0010833) | 2.99050065 |
| 84 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.97760598 |
| 85 | DNA strand renaturation (GO:0000733) | 2.97564313 |
| 86 | rRNA metabolic process (GO:0016072) | 2.96255714 |
| 87 | heterochromatin organization (GO:0070828) | 2.96097169 |
| 88 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.95601586 |
| 89 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.95527388 |
| 90 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.95527388 |
| 91 | regulation of sister chromatid segregation (GO:0033045) | 2.95527388 |
| 92 | protein neddylation (GO:0045116) | 2.95137780 |
| 93 | regulation of translation in response to stress (GO:0043555) | 2.94498501 |
| 94 | nuclear pore complex assembly (GO:0051292) | 2.94317729 |
| 95 | negative regulation of ligase activity (GO:0051352) | 2.94100994 |
| 96 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.94100994 |
| 97 | negative regulation of RNA splicing (GO:0033119) | 2.93180451 |
| 98 | negative regulation of mRNA processing (GO:0050686) | 2.92497343 |
| 99 | regulation of spindle organization (GO:0090224) | 2.92398731 |
| 100 | mitotic spindle assembly checkpoint (GO:0007094) | 2.92292257 |
| 101 | negative regulation of chromosome segregation (GO:0051985) | 2.91376782 |
| 102 | negative regulation of sister chromatid segregation (GO:0033046) | 2.89306680 |
| 103 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.89306680 |
| 104 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.89306680 |
| 105 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.89306680 |
| 106 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89262074 |
| 107 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89262074 |
| 108 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89262074 |
| 109 | ribosomal large subunit biogenesis (GO:0042273) | 2.89191432 |
| 110 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.89090427 |
| 111 | translesion synthesis (GO:0019985) | 2.88809588 |
| 112 | negative regulation of translational initiation (GO:0045947) | 2.87907497 |
| 113 | methionine biosynthetic process (GO:0009086) | 2.87236240 |
| 114 | DNA duplex unwinding (GO:0032508) | 2.86934599 |
| 115 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.85437333 |
| 116 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84992635 |
| 117 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84992635 |
| 118 | negative regulation of DNA recombination (GO:0045910) | 2.84559281 |
| 119 | establishment of chromosome localization (GO:0051303) | 2.83788279 |
| 120 | peptidyl-histidine modification (GO:0018202) | 2.83071235 |
| 121 | cell cycle G1/S phase transition (GO:0044843) | 2.82816705 |
| 122 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.82816705 |
| 123 | spliceosomal snRNP assembly (GO:0000387) | 2.82746365 |
| 124 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.82510731 |
| 125 | termination of RNA polymerase III transcription (GO:0006386) | 2.82510731 |
| 126 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.82143152 |
| 127 | regulation of chromosome segregation (GO:0051983) | 2.81718099 |
| 128 | spindle assembly checkpoint (GO:0071173) | 2.81710100 |
| 129 | DNA geometric change (GO:0032392) | 2.81316648 |
| 130 | telomere maintenance via recombination (GO:0000722) | 2.81014375 |
| 131 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.80836871 |
| 132 | mitotic recombination (GO:0006312) | 2.79493283 |
| 133 | positive regulation of ligase activity (GO:0051351) | 2.79032526 |
| 134 | mitotic spindle checkpoint (GO:0071174) | 2.76296356 |
| 135 | regulation of centrosome cycle (GO:0046605) | 2.75763344 |
| 136 | mitotic G1/S transition checkpoint (GO:0044819) | 2.74196511 |
| 137 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.73920571 |
| 138 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.73465404 |
| 139 | pseudouridine synthesis (GO:0001522) | 2.73064506 |
| 140 | spindle checkpoint (GO:0031577) | 2.72199761 |
| 141 | folic acid-containing compound metabolic process (GO:0006760) | 2.72181250 |
| 142 | positive regulation of chromosome segregation (GO:0051984) | 2.70206270 |
| 143 | S-adenosylmethionine metabolic process (GO:0046500) | 2.69270033 |
| 144 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.68684194 |
| 145 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.67919856 |
| 146 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.67919856 |
| 147 | histone H2A monoubiquitination (GO:0035518) | 2.66605851 |
| 148 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66288781 |
| 149 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66288781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.98168986 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.94941425 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.76573991 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.70638017 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.33067433 |
| 6 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.19684525 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.12054363 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.09484455 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.06520870 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95013441 |
| 11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.94256663 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.85112810 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.81780955 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.72792028 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.71828135 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.53034551 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50147264 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.45336464 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.45274836 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.36856636 |
| 21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.24535155 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.21262432 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.19635886 |
| 24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.19583441 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.16670495 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.11487826 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.07438325 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06733266 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05467018 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05263665 |
| 31 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.05253295 |
| 32 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.98362462 |
| 33 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96371272 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.95250435 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95039612 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.94175951 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86151676 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84464539 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80028642 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79596755 |
| 41 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.72274801 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69721503 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67695052 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64767781 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60947492 |
| 46 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.60792381 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57960375 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57821976 |
| 49 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.55298416 |
| 50 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53035744 |
| 51 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.51779010 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49961113 |
| 53 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48816285 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48759277 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48187176 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47655841 |
| 57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.41501936 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41466492 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38230299 |
| 60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36132792 |
| 61 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.34923260 |
| 62 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.33408558 |
| 63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.31438255 |
| 64 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.30841800 |
| 65 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29843177 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29821642 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29467302 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29129741 |
| 69 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28578209 |
| 70 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.28303008 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27911228 |
| 72 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27701800 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27008597 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26519224 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26297707 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26273774 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24928868 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23334623 |
| 79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21895649 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18269110 |
| 81 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18197543 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17253351 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15991752 |
| 84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15306663 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14732467 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14519471 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13635218 |
| 88 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12833791 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11943981 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05362098 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04366301 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04321588 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01190784 |
| 94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00631605 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00352126 |
| 96 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99211646 |
| 97 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.98247371 |
| 98 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98137932 |
| 99 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98137932 |
| 100 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98137932 |
| 101 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.97663566 |
| 102 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.97436397 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94964344 |
| 104 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93361372 |
| 105 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.86627799 |
| 106 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85201843 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84702693 |
| 108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83636637 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82712368 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.82187975 |
| 111 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81961046 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81089454 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80198280 |
| 114 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.79801561 |
| 115 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.79591847 |
| 116 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77179919 |
| 117 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.76054110 |
| 118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.75282647 |
| 119 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.75207484 |
| 120 | MYB_26560356_Chip-Seq_TH2_Human | 0.74213180 |
| 121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.74032005 |
| 122 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.73507411 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.71960439 |
| 124 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.71731739 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71447012 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 0.71062416 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.70418958 |
| 128 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70309171 |
| 129 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.69915495 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.69833772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.77916164 |
| 2 | MP0003111_abnormal_nucleus_morphology | 4.30552267 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.29570615 |
| 4 | MP0008057_abnormal_DNA_replication | 4.22150653 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.79559308 |
| 6 | MP0003077_abnormal_cell_cycle | 3.68480115 |
| 7 | MP0008058_abnormal_DNA_repair | 2.95979005 |
| 8 | MP0003941_abnormal_skin_development | 2.69133487 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.64494138 |
| 10 | MP0003123_paternal_imprinting | 2.54117596 |
| 11 | MP0001730_embryonic_growth_arrest | 2.51310578 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.47122432 |
| 13 | MP0009697_abnormal_copulation | 2.40496710 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.25063484 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.22491766 |
| 16 | MP0001293_anophthalmia | 2.18108056 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.09737635 |
| 18 | MP0002938_white_spotting | 2.03062885 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 1.97187577 |
| 20 | MP0000350_abnormal_cell_proliferation | 1.93959012 |
| 21 | MP0003984_embryonic_growth_retardation | 1.91913391 |
| 22 | MP0002088_abnormal_embryonic_growth/wei | 1.85381603 |
| 23 | MP0001672_abnormal_embryogenesis/_devel | 1.81477354 |
| 24 | MP0005380_embryogenesis_phenotype | 1.81477354 |
| 25 | MP0001697_abnormal_embryo_size | 1.81283751 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.80275566 |
| 27 | MP0002398_abnormal_bone_marrow | 1.79744475 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.79555804 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.78923938 |
| 30 | MP0001529_abnormal_vocalization | 1.77608141 |
| 31 | MP0003786_premature_aging | 1.77345479 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.76954497 |
| 33 | MP0003937_abnormal_limbs/digits/tail_de | 1.75914069 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.71486905 |
| 35 | MP0003646_muscle_fatigue | 1.69535188 |
| 36 | MP0003136_yellow_coat_color | 1.67452114 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.65602443 |
| 38 | MP0002080_prenatal_lethality | 1.65127821 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.64268384 |
| 40 | MP0002722_abnormal_immune_system | 1.61437171 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.60835246 |
| 42 | MP0003718_maternal_effect | 1.57174255 |
| 43 | MP0002254_reproductive_system_inflammat | 1.55057731 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.54357588 |
| 45 | MP0003221_abnormal_cardiomyocyte_apopto | 1.53729814 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.52481811 |
| 47 | MP0001800_abnormal_humoral_immune | 1.51766304 |
| 48 | MP0003119_abnormal_digestive_system | 1.51212563 |
| 49 | MP0000358_abnormal_cell_content/ | 1.43871705 |
| 50 | MP0010307_abnormal_tumor_latency | 1.41696494 |
| 51 | MP0004133_heterotaxia | 1.41112438 |
| 52 | MP0003186_abnormal_redox_activity | 1.40896890 |
| 53 | MP0008789_abnormal_olfactory_epithelium | 1.39514273 |
| 54 | MP0002429_abnormal_blood_cell | 1.36409945 |
| 55 | MP0000716_abnormal_immune_system | 1.36212142 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.34667078 |
| 57 | MP0001727_abnormal_embryo_implantation | 1.31856476 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.31711293 |
| 59 | MP0000313_abnormal_cell_death | 1.31690529 |
| 60 | MP0004233_abnormal_muscle_weight | 1.29143087 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.28927188 |
| 62 | MP0002269_muscular_atrophy | 1.27057682 |
| 63 | MP0009672_abnormal_birth_weight | 1.26483114 |
| 64 | MP0002086_abnormal_extraembryonic_tissu | 1.25548312 |
| 65 | MP0001286_abnormal_eye_development | 1.25035387 |
| 66 | MP0002697_abnormal_eye_size | 1.22759735 |
| 67 | MP0001188_hyperpigmentation | 1.22122089 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.19490855 |
| 69 | MP0002085_abnormal_embryonic_tissue | 1.18342162 |
| 70 | MP0000747_muscle_weakness | 1.18289811 |
| 71 | MP0002233_abnormal_nose_morphology | 1.16994033 |
| 72 | MP0000490_abnormal_crypts_of | 1.16384211 |
| 73 | MP0004197_abnormal_fetal_growth/weight/ | 1.16362695 |
| 74 | MP0003121_genomic_imprinting | 1.16167851 |
| 75 | MP0005499_abnormal_olfactory_system | 1.15042725 |
| 76 | MP0005394_taste/olfaction_phenotype | 1.15042725 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.14634634 |
| 78 | MP0002420_abnormal_adaptive_immunity | 1.11339745 |
| 79 | MP0004147_increased_porphyrin_level | 1.09599718 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.08733604 |
| 81 | MP0002822_catalepsy | 1.08447027 |
| 82 | MP0001819_abnormal_immune_cell | 1.08424875 |
| 83 | MP0005384_cellular_phenotype | 1.08326677 |
| 84 | MP0003315_abnormal_perineum_morphology | 1.06993842 |
| 85 | MP0002111_abnormal_tail_morphology | 1.06309684 |
| 86 | MP0005666_abnormal_adipose_tissue | 1.06022028 |
| 87 | MP0002084_abnormal_developmental_patter | 1.05783673 |
| 88 | MP0003122_maternal_imprinting | 1.05658596 |
| 89 | MP0000372_irregular_coat_pigmentation | 1.05562759 |
| 90 | MP0002210_abnormal_sex_determination | 1.03429291 |
| 91 | MP0002723_abnormal_immune_serum | 1.03042186 |
| 92 | MP0008995_early_reproductive_senescence | 1.01531140 |
| 93 | MP0000537_abnormal_urethra_morphology | 1.01429884 |
| 94 | MP0005621_abnormal_cell_physiology | 1.00821799 |
| 95 | MP0002751_abnormal_autonomic_nervous | 1.00701111 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.99324030 |
| 97 | MP0001929_abnormal_gametogenesis | 0.98947682 |
| 98 | MP0000049_abnormal_middle_ear | 0.98498264 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.97121008 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.96533997 |
| 101 | MP0005451_abnormal_body_composition | 0.93020929 |
| 102 | MP0001661_extended_life_span | 0.92666030 |
| 103 | MP0001145_abnormal_male_reproductive | 0.92091279 |
| 104 | MP0002160_abnormal_reproductive_system | 0.91291261 |
| 105 | MP0002163_abnormal_gland_morphology | 0.89056506 |
| 106 | MP0009840_abnormal_foam_cell | 0.87815285 |
| 107 | MP0005670_abnormal_white_adipose | 0.86297494 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84201420 |
| 109 | MP0005671_abnormal_response_to | 0.82681207 |
| 110 | MP0003303_peritoneal_inflammation | 0.81001810 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.80857167 |
| 112 | MP0001835_abnormal_antigen_presentation | 0.80825016 |
| 113 | MP0004084_abnormal_cardiac_muscle | 0.78030799 |
| 114 | MP0002090_abnormal_vision | 0.77692991 |
| 115 | MP0003755_abnormal_palate_morphology | 0.75464335 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.74412641 |
| 117 | MP0004130_abnormal_muscle_cell | 0.74230034 |
| 118 | MP0000685_abnormal_immune_system | 0.73372334 |
| 119 | MP0009703_decreased_birth_body | 0.73339898 |
| 120 | MP0002970_abnormal_white_adipose | 0.73179808 |
| 121 | MP0008770_decreased_survivor_rate | 0.72215591 |
| 122 | MP0001119_abnormal_female_reproductive | 0.70954946 |
| 123 | MP0005391_vision/eye_phenotype | 0.70940724 |
| 124 | MP0000579_abnormal_nail_morphology | 0.70867058 |
| 125 | MP0003861_abnormal_nervous_system | 0.70540771 |
| 126 | MP0000609_abnormal_liver_physiology | 0.70365029 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.69482138 |
| 128 | MP0000653_abnormal_sex_gland | 0.69207685 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.68839123 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.67669288 |
| 131 | MP0002092_abnormal_eye_morphology | 0.67667102 |
| 132 | MP0002736_abnormal_nociception_after | 0.66775694 |
| 133 | MP0005253_abnormal_eye_physiology | 0.65102679 |
| 134 | MP0001873_stomach_inflammation | 0.64522296 |
| 135 | MP0003698_abnormal_male_reproductive | 0.64004633 |
| 136 | MP0005395_other_phenotype | 0.62886960 |
| 137 | MP0000631_abnormal_neuroendocrine_gland | 0.62642257 |
| 138 | MP0005375_adipose_tissue_phenotype | 0.62187666 |
| 139 | MP0001853_heart_inflammation | 0.61744502 |
| 140 | MP0002102_abnormal_ear_morphology | 0.60755311 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.60643100 |
| 142 | MP0005000_abnormal_immune_tolerance | 0.60076879 |
| 143 | MP0005387_immune_system_phenotype | 0.59934092 |
| 144 | MP0001790_abnormal_immune_system | 0.59934092 |
| 145 | MP0000428_abnormal_craniofacial_morphol | 0.59285838 |
| 146 | MP0001299_abnormal_eye_distance/ | 0.59171754 |
| 147 | MP0005187_abnormal_penis_morphology | 0.58882139 |
| 148 | MP0001545_abnormal_hematopoietic_system | 0.58874871 |
| 149 | MP0005397_hematopoietic_system_phenotyp | 0.58874871 |
| 150 | MP0001177_atelectasis | 0.58439245 |
| 151 | MP0005367_renal/urinary_system_phenotyp | 0.58359185 |
| 152 | MP0000516_abnormal_urinary_system | 0.58359185 |
| 153 | MP0001984_abnormal_olfaction | 0.58211100 |
| 154 | MP0002106_abnormal_muscle_physiology | 0.56803075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ependymoma (HP:0002888) | 4.22247140 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.08472256 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.95167074 |
| 4 | Carpal bone hypoplasia (HP:0001498) | 3.86333096 |
| 5 | Breast hypoplasia (HP:0003187) | 3.64796608 |
| 6 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.63400693 |
| 7 | Cerebral hypomyelination (HP:0006808) | 3.60317272 |
| 8 | Agnosia (HP:0010524) | 3.59163561 |
| 9 | Chromsome breakage (HP:0040012) | 3.58882714 |
| 10 | Irregular epiphyses (HP:0010582) | 3.51440790 |
| 11 | Meckel diverticulum (HP:0002245) | 3.35637942 |
| 12 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.20259025 |
| 13 | Abnormality of the ileum (HP:0001549) | 3.16904572 |
| 14 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.02569065 |
| 15 | Abnormality of chromosome stability (HP:0003220) | 2.96173122 |
| 16 | Small epiphyses (HP:0010585) | 2.95579641 |
| 17 | Abnormal lung lobation (HP:0002101) | 2.94835092 |
| 18 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.92838014 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 2.90466703 |
| 20 | Absent epiphyses (HP:0010577) | 2.89785402 |
| 21 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.89785402 |
| 22 | Abnormality of the preputium (HP:0100587) | 2.86502859 |
| 23 | IgM deficiency (HP:0002850) | 2.82412288 |
| 24 | Abnormality of the lower motor neuron (HP:0002366) | 2.66337274 |
| 25 | Progressive macrocephaly (HP:0004481) | 2.63534597 |
| 26 | Reticulocytopenia (HP:0001896) | 2.60687106 |
| 27 | Duodenal stenosis (HP:0100867) | 2.57913565 |
| 28 | Small intestinal stenosis (HP:0012848) | 2.57913565 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56981469 |
| 30 | Shoulder girdle muscle weakness (HP:0003547) | 2.55985834 |
| 31 | Multiple enchondromatosis (HP:0005701) | 2.55614236 |
| 32 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.50533757 |
| 33 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.50533757 |
| 34 | Hypoglycemic coma (HP:0001325) | 2.49348164 |
| 35 | Microvesicular hepatic steatosis (HP:0001414) | 2.49104176 |
| 36 | Cerebral edema (HP:0002181) | 2.48641872 |
| 37 | Hyperglycinemia (HP:0002154) | 2.48210759 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.47303237 |
| 39 | Patellar aplasia (HP:0006443) | 2.46772141 |
| 40 | Glossoptosis (HP:0000162) | 2.45212707 |
| 41 | Flattened epiphyses (HP:0003071) | 2.44598951 |
| 42 | Toxemia of pregnancy (HP:0100603) | 2.43967527 |
| 43 | Medulloblastoma (HP:0002885) | 2.40090463 |
| 44 | Abnormality of the duodenum (HP:0002246) | 2.35619950 |
| 45 | CNS hypomyelination (HP:0003429) | 2.35520348 |
| 46 | Abnormality of the astrocytes (HP:0100707) | 2.32109457 |
| 47 | Astrocytoma (HP:0009592) | 2.32109457 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.32096130 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.31696702 |
| 50 | Absent radius (HP:0003974) | 2.30099718 |
| 51 | Neoplasm of the rectum (HP:0100743) | 2.29925163 |
| 52 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.28902862 |
| 53 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.27521248 |
| 54 | T lymphocytopenia (HP:0005403) | 2.26205428 |
| 55 | Cortical dysplasia (HP:0002539) | 2.26125087 |
| 56 | Horseshoe kidney (HP:0000085) | 2.26012003 |
| 57 | Acute necrotizing encephalopathy (HP:0006965) | 2.24682729 |
| 58 | Upper motor neuron abnormality (HP:0002127) | 2.24288871 |
| 59 | Areflexia of lower limbs (HP:0002522) | 2.23533231 |
| 60 | Methylmalonic acidemia (HP:0002912) | 2.22521250 |
| 61 | Embryonal renal neoplasm (HP:0011794) | 2.21343251 |
| 62 | Absent forearm bone (HP:0003953) | 2.20536856 |
| 63 | Aplasia involving forearm bones (HP:0009822) | 2.20536856 |
| 64 | Basal cell carcinoma (HP:0002671) | 2.20407833 |
| 65 | Rough bone trabeculation (HP:0100670) | 2.19205185 |
| 66 | Pelvic girdle muscle weakness (HP:0003749) | 2.19158773 |
| 67 | Rhabdomyosarcoma (HP:0002859) | 2.15405694 |
| 68 | Triphalangeal thumb (HP:0001199) | 2.14458540 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.14059181 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.13640810 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11743493 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.11743493 |
| 73 | Sloping forehead (HP:0000340) | 2.11591326 |
| 74 | Septo-optic dysplasia (HP:0100842) | 2.11436525 |
| 75 | Recurrent viral infections (HP:0004429) | 2.09079379 |
| 76 | Neoplasm of the small intestine (HP:0100833) | 2.06728576 |
| 77 | Neoplasm of the colon (HP:0100273) | 2.06315658 |
| 78 | Lactic acidosis (HP:0003128) | 2.06095340 |
| 79 | Hyperglycinuria (HP:0003108) | 2.05873470 |
| 80 | Angiofibromas (HP:0010615) | 2.05165506 |
| 81 | Adenoma sebaceum (HP:0009720) | 2.05165506 |
| 82 | Neoplasm of the adrenal gland (HP:0100631) | 2.04532233 |
| 83 | Hepatic necrosis (HP:0002605) | 2.04492048 |
| 84 | Increased CSF lactate (HP:0002490) | 2.03320472 |
| 85 | Chronic otitis media (HP:0000389) | 2.02099027 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.01841850 |
| 87 | Abnormality of alanine metabolism (HP:0010916) | 2.01841850 |
| 88 | Hyperalaninemia (HP:0003348) | 2.01841850 |
| 89 | Microretrognathia (HP:0000308) | 2.00770537 |
| 90 | Abnormality of glycolysis (HP:0004366) | 2.00710958 |
| 91 | Increased serum pyruvate (HP:0003542) | 2.00710958 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98919202 |
| 93 | Colon cancer (HP:0003003) | 1.98814775 |
| 94 | Postnatal microcephaly (HP:0005484) | 1.97265014 |
| 95 | Irregular vertebral endplates (HP:0003301) | 1.97018438 |
| 96 | Hepatocellular necrosis (HP:0001404) | 1.96398430 |
| 97 | Hypoplasia of the pons (HP:0012110) | 1.96359898 |
| 98 | Abnormality of T cell number (HP:0011839) | 1.95570299 |
| 99 | Methylmalonic aciduria (HP:0012120) | 1.95472973 |
| 100 | Ectopic kidney (HP:0000086) | 1.95349656 |
| 101 | Megaloblastic anemia (HP:0001889) | 1.95000361 |
| 102 | IgG deficiency (HP:0004315) | 1.94444073 |
| 103 | Increased serum lactate (HP:0002151) | 1.94112632 |
| 104 | Hypoplastic pelvis (HP:0008839) | 1.93610151 |
| 105 | Amaurosis fugax (HP:0100576) | 1.93153587 |
| 106 | Abnormality of the pons (HP:0007361) | 1.92652961 |
| 107 | Stenosis of the external auditory canal (HP:0000402) | 1.91869305 |
| 108 | Abnormality of the calcaneus (HP:0008364) | 1.91818773 |
| 109 | Abnormality of T cells (HP:0002843) | 1.91605909 |
| 110 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90875253 |
| 111 | Neoplasm of the pancreas (HP:0002894) | 1.90844172 |
| 112 | Absent thumb (HP:0009777) | 1.89545196 |
| 113 | Acute encephalopathy (HP:0006846) | 1.89245064 |
| 114 | CNS demyelination (HP:0007305) | 1.88343057 |
| 115 | Panhypogammaglobulinemia (HP:0003139) | 1.87752015 |
| 116 | Abnormality of the labia minora (HP:0012880) | 1.87213171 |
| 117 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.87133745 |
| 118 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.87133745 |
| 119 | Rhabdomyolysis (HP:0003201) | 1.86988973 |
| 120 | Abnormality of homocysteine metabolism (HP:0010919) | 1.86882941 |
| 121 | Homocystinuria (HP:0002156) | 1.86882941 |
| 122 | Abnormality of the carotid arteries (HP:0005344) | 1.85744874 |
| 123 | Recurrent bronchitis (HP:0002837) | 1.84160442 |
| 124 | Degeneration of anterior horn cells (HP:0002398) | 1.83812798 |
| 125 | Abnormality of the anterior horn cell (HP:0006802) | 1.83812798 |
| 126 | Abnormal glycosylation (HP:0012345) | 1.83531020 |
| 127 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83531020 |
| 128 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83531020 |
| 129 | Abnormal protein glycosylation (HP:0012346) | 1.83531020 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 1.83131661 |
| 131 | Exercise intolerance (HP:0003546) | 1.82420096 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.82057778 |
| 133 | Emotional lability (HP:0000712) | 1.81825548 |
| 134 | Cafe-au-lait spot (HP:0000957) | 1.81142163 |
| 135 | Bilateral microphthalmos (HP:0007633) | 1.80105729 |
| 136 | Glioma (HP:0009733) | 1.79867534 |
| 137 | Biliary tract neoplasm (HP:0100574) | 1.79783327 |
| 138 | Supernumerary spleens (HP:0009799) | 1.79293363 |
| 139 | Renal Fanconi syndrome (HP:0001994) | 1.77738049 |
| 140 | Papilloma (HP:0012740) | 1.77406427 |
| 141 | Verrucae (HP:0200043) | 1.77406427 |
| 142 | Impulsivity (HP:0100710) | 1.76730109 |
| 143 | Abnormality of chromosome segregation (HP:0002916) | 1.76655705 |
| 144 | Myelodysplasia (HP:0002863) | 1.76046488 |
| 145 | Increased nuchal translucency (HP:0010880) | 1.75976132 |
| 146 | Leukodystrophy (HP:0002415) | 1.75697384 |
| 147 | Neoplasm of striated muscle (HP:0009728) | 1.75610267 |
| 148 | Macrocytic anemia (HP:0001972) | 1.75568977 |
| 149 | Facial hemangioma (HP:0000329) | 1.75518169 |
| 150 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.75125263 |
| 151 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.75125263 |
| 152 | Clubbing of toes (HP:0100760) | 1.74593082 |
| 153 | Mitochondrial inheritance (HP:0001427) | 1.74485308 |
| 154 | Cellular immunodeficiency (HP:0005374) | 1.73297963 |
| 155 | Absent septum pellucidum (HP:0001331) | 1.73297623 |
| 156 | Entropion (HP:0000621) | 1.73093700 |
| 157 | Abnormality of abdominal situs (HP:0011620) | 1.70682502 |
| 158 | Abdominal situs inversus (HP:0003363) | 1.70682502 |
| 159 | Agammaglobulinemia (HP:0004432) | 1.70665998 |
| 160 | Urinary urgency (HP:0000012) | 1.70569800 |
| 161 | Pancytopenia (HP:0001876) | 1.70529023 |
| 162 | Metaphyseal cupping (HP:0003021) | 1.70495915 |
| 163 | Facial cleft (HP:0002006) | 1.68679264 |
| 164 | Cleft eyelid (HP:0000625) | 1.67052554 |
| 165 | Duplicated collecting system (HP:0000081) | 1.66436041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.11404802 |
| 2 | WEE1 | 3.96307478 |
| 3 | CDC7 | 3.84728357 |
| 4 | EIF2AK1 | 3.59987618 |
| 5 | TSSK6 | 3.53390668 |
| 6 | VRK2 | 3.30360311 |
| 7 | WNK3 | 3.20192655 |
| 8 | MAP4K1 | 2.72920291 |
| 9 | PBK | 2.66339127 |
| 10 | MKNK2 | 2.44133231 |
| 11 | BRSK2 | 2.39995153 |
| 12 | SRPK1 | 2.33472584 |
| 13 | TRIM28 | 2.29608167 |
| 14 | NEK2 | 2.22993266 |
| 15 | STK16 | 2.06976378 |
| 16 | CDK12 | 2.04419128 |
| 17 | GRK6 | 2.03783184 |
| 18 | EIF2AK3 | 2.03588908 |
| 19 | PDK4 | 2.03174276 |
| 20 | PDK3 | 2.03174276 |
| 21 | NUAK1 | 2.01735338 |
| 22 | NME2 | 1.89237165 |
| 23 | STK10 | 1.85896888 |
| 24 | TAF1 | 1.83384889 |
| 25 | NEK1 | 1.78193633 |
| 26 | MAP3K10 | 1.69618042 |
| 27 | CCNB1 | 1.67835779 |
| 28 | BRSK1 | 1.65376664 |
| 29 | PLK1 | 1.59491928 |
| 30 | SCYL2 | 1.59080753 |
| 31 | DYRK3 | 1.58551027 |
| 32 | BMPR1B | 1.55066081 |
| 33 | TESK2 | 1.43645372 |
| 34 | MAP3K8 | 1.42899497 |
| 35 | TTK | 1.40793099 |
| 36 | EEF2K | 1.39460435 |
| 37 | LRRK2 | 1.25505289 |
| 38 | STK3 | 1.22027373 |
| 39 | ATR | 1.17557629 |
| 40 | PASK | 1.16674880 |
| 41 | TLK1 | 1.15229599 |
| 42 | TNIK | 1.12014347 |
| 43 | CHEK1 | 1.11245000 |
| 44 | PLK3 | 1.11139850 |
| 45 | CSNK1G1 | 1.09993114 |
| 46 | NME1 | 1.08496024 |
| 47 | BCKDK | 1.05982251 |
| 48 | TYK2 | 1.05458144 |
| 49 | CDK4 | 1.03502689 |
| 50 | EIF2AK2 | 1.02432591 |
| 51 | AURKB | 1.01301199 |
| 52 | PDK2 | 0.99046300 |
| 53 | ALK | 0.96246846 |
| 54 | RPS6KB2 | 0.94382305 |
| 55 | TAOK1 | 0.93619808 |
| 56 | MKNK1 | 0.93441650 |
| 57 | CSNK1G3 | 0.93194150 |
| 58 | RPS6KA4 | 0.92915297 |
| 59 | VRK1 | 0.90692429 |
| 60 | ERBB4 | 0.88152485 |
| 61 | CDK7 | 0.87738408 |
| 62 | PNCK | 0.86374095 |
| 63 | EPHA2 | 0.85916210 |
| 64 | CSNK1G2 | 0.84982951 |
| 65 | PAK4 | 0.84638170 |
| 66 | AKT3 | 0.84264734 |
| 67 | DYRK2 | 0.84121735 |
| 68 | MAP3K12 | 0.82447111 |
| 69 | PKN2 | 0.82069539 |
| 70 | PLK2 | 0.80684193 |
| 71 | ERBB3 | 0.79055398 |
| 72 | ITK | 0.75484900 |
| 73 | PIM1 | 0.74939311 |
| 74 | STK24 | 0.74673082 |
| 75 | CDK19 | 0.74402530 |
| 76 | STK38L | 0.72692715 |
| 77 | STK4 | 0.72468069 |
| 78 | MAP4K2 | 0.71894432 |
| 79 | LATS1 | 0.71139439 |
| 80 | ACVR1B | 0.70999730 |
| 81 | CDK2 | 0.70634509 |
| 82 | CSF1R | 0.69661885 |
| 83 | TRIB3 | 0.69545116 |
| 84 | MAP2K3 | 0.69468083 |
| 85 | PLK4 | 0.69049252 |
| 86 | CSNK1A1L | 0.68956889 |
| 87 | MELK | 0.67370701 |
| 88 | CAMKK2 | 0.64369993 |
| 89 | TTN | 0.63371143 |
| 90 | BRD4 | 0.62801334 |
| 91 | MTOR | 0.61979795 |
| 92 | CLK1 | 0.61256647 |
| 93 | CHEK2 | 0.59115639 |
| 94 | ATM | 0.58581452 |
| 95 | AURKA | 0.57646962 |
| 96 | BRAF | 0.57514977 |
| 97 | BTK | 0.56334793 |
| 98 | OXSR1 | 0.56039353 |
| 99 | INSRR | 0.55731442 |
| 100 | ZAP70 | 0.55388198 |
| 101 | CDK1 | 0.55138501 |
| 102 | FGFR1 | 0.53790020 |
| 103 | SYK | 0.50763450 |
| 104 | MARK3 | 0.50591322 |
| 105 | CSNK2A2 | 0.49707414 |
| 106 | KSR1 | 0.46548575 |
| 107 | GRK1 | 0.44423274 |
| 108 | MAPKAPK5 | 0.44034992 |
| 109 | MAP3K11 | 0.43163977 |
| 110 | DAPK1 | 0.43044550 |
| 111 | PRKCI | 0.42839040 |
| 112 | MAP3K3 | 0.41457531 |
| 113 | TXK | 0.40544767 |
| 114 | FLT3 | 0.40363864 |
| 115 | STK39 | 0.39936874 |
| 116 | MINK1 | 0.39734669 |
| 117 | PAK1 | 0.38060375 |
| 118 | MAP3K4 | 0.37623022 |
| 119 | WNK4 | 0.37337225 |
| 120 | CDK8 | 0.33521583 |
| 121 | PRKCG | 0.33024879 |
| 122 | RIPK4 | 0.32360234 |
| 123 | TIE1 | 0.30569784 |
| 124 | LIMK1 | 0.29928428 |
| 125 | RPS6KA5 | 0.29847285 |
| 126 | TGFBR1 | 0.29370867 |
| 127 | CDK3 | 0.28836044 |
| 128 | MST4 | 0.28723968 |
| 129 | PRKDC | 0.28441334 |
| 130 | TBK1 | 0.28008876 |
| 131 | LCK | 0.27044895 |
| 132 | CDK18 | 0.26404221 |
| 133 | CDK14 | 0.25254926 |
| 134 | BCR | 0.25004018 |
| 135 | MAP2K7 | 0.24607707 |
| 136 | CSNK2A1 | 0.24085012 |
| 137 | CSNK1E | 0.23794379 |
| 138 | RAF1 | 0.22134862 |
| 139 | LYN | 0.20937178 |
| 140 | RPS6KA6 | 0.20162182 |
| 141 | ZAK | 0.18405399 |
| 142 | CSNK1D | 0.16963275 |
| 143 | RPS6KC1 | 0.16162273 |
| 144 | RPS6KL1 | 0.16162273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.02914390 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.02796206 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.02210981 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.62178126 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.37395025 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 3.20756720 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.17275381 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 3.01149363 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 2.56950081 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.52060850 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.51250977 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.38675727 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.37263381 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.32433072 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.17646377 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.17145369 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.09186552 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.67668939 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.57569328 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56613426 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55682134 |
| 22 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.50715714 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50453736 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49638215 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49577377 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.48071527 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.41212792 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36981568 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36666707 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33147276 |
| 31 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.26937745 |
| 32 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.26809967 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21480652 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21450118 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21075195 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17336607 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09860382 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09683561 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.07415435 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07139571 |
| 41 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.07113027 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02238373 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 0.98185935 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96733640 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95848362 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93469588 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88908585 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87507595 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83304252 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79794127 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79726756 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78412672 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75017901 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72792261 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71754410 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70711205 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68436126 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67662195 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65251941 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64989829 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62953319 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61169378 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59377761 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58727137 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58300265 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56159848 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54408592 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51839441 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51693102 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51126410 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.50435792 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50388247 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50338563 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49164260 |
| 75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48077131 |
| 76 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45338880 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45095623 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43922942 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42436494 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.41671436 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41590852 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41005151 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39808567 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.39321340 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37716975 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37386968 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37136909 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36890593 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36812020 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36212093 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35160111 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34448311 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34342626 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34220963 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33113318 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32999303 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.32900120 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32109087 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31763684 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30887138 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.30775326 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30436019 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28533259 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.28011068 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.27545709 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27328989 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26858977 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26698226 |
| 109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25986428 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25596794 |
| 111 | Protein export_Homo sapiens_hsa03060 | 0.24964045 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.24807722 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24172415 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.23704501 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23626778 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23540612 |
| 117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23034297 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.22028448 |
| 119 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20315902 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19970211 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19257492 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19042110 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18305706 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17882246 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17600034 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.16767350 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16575527 |
| 128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16408505 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15735537 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15714030 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.15570774 |
| 132 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.15372924 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15296713 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.14565519 |
| 135 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.14559495 |
| 136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.14409392 |
| 137 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.14408842 |

